 |
Children
with diabetes 'need more NHS help' |
| |
The growing numbers of children with obesity-related
diabetes need more radical help from the NHS if they are to have
any chance of a normal, healthy life, according to experts (Guardian,
UK) |
| |
|
|
AstraZeneca
tried to 'bury' bad news on Seroquel drug |
| |
The Anglo-Swedish drugs group is being sued
by a total of 9,200 patients, most of whom allege that the Seroquel
treatment for psychiatric disorders gave them diabetes (Times,
UK) |
| |
|
|
The
geospatial relation between UV solar radiation and type 1 diabetes
in Newfoundland |
| |
This study suggests that erythemal UVB radiation
may be geospatially associated with the incidence of T1DM in Newfoundland
(Acta Diabetologica) |
| |
|
|
Insulin
drug study shows significant improvements in more than 52,000
diabetic patients |
| |
A major international diabetes study of more
than 52,000 patients from eight countries has shown that using
biphasic BIAsp 30 insulin resulted in significant clinical improvements
and greater patient satisfaction (EurekAlert) |
| |
|
|
Insulin-induced
weight gain and cardiovascular events in patients with type 2
diabetes. A report from the DIGAMI 2 study |
| |
Initiation of insulin treatment after myocardial
infarction was associated with a significant increase in weight
and incidence of reinfarction. The increase in weight did, however,
not explain the increased rate of reinfarction (Diabetes, Obesity
and Metabolism) |
| |
|
|
Generex
Oral-lyn™ to be presented at International Conference on Advances in Diabetes and Insulin
Therapy |
| |
Professor Pozzilli will present his paper entitled
Buccal Spray Insulin for Treatment of Diabetes. The paper concludes
that Generex Oral-lyn is able to control plasma glucose as well
as fast-acting injectable insulin analogs (lispro, aspart, glulisine)
and can be used to control post-prandial hyperglycaemia (Business
Wire) |
| |
|
|
NZSSD
Position Statement on standardisation of reporting units for
HbA1c and application of estimated average glucose (eAG) |
| |
New Zealand clinical laboratories should implement
dual reporting of HbA1c in both molar units (mmol/mol) and currently
reported DCCT-aligned units (%), as recommended in a consensus
statement from ADA, EASD, IFCC and IDF, published in 2007. After
a period of two years from the time of implementation it is envisaged
that only molar units will be reported (NZSSD) |
| |
|
